RSS

Engineered Neural Tissue (EngNT)

The UCL Technology Fund (UCLTF) and UK Innovation & Science Seed Fund (UKI2S), with support from Innovate UK, have invested in cell therapy company Glialign — a spin out company from UCL. Read more

News